View the ALLRECOV registration information details.
Back to drug list
ItemsDrug Registration information
ID1951
No1951
Brand NameALLRECOV
IngredientsNALTREXONE HYDROCHLORIDE 150 MG
Dosage FormIMPLANT
Primary PackagingVIAL
Storage
Shelf Life24 MONTHS
Pack SizeBOX OF 10 TABLETS/VIAL
Dispensing Category
ATC Classification
Pharmaceutical Class
Indicationsfor the prevention of relapse following opioid detoxification in patients with opioid dependence.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionThe product is a light yellow to yellow cylindrical tablet
Note
License OwnerMUNGMISAI PHARMACEUTICAL SOLE CO.,LTD
ManufacturerSHENZHEN SCIENCARE PHARMACEUTICAL CO., LTD
CountryCHINA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No01 I 5859/25
FDD Registration Date07/03/2025
Expiry Date06/03/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA